We are live on ! Find out more
KXA

KPCB XVI Associates Portfolio holdings

AUM $225M
1-Year Est. Return 26.26%
This Fund
S&P 500
This Quarter Est. Return
-20.01%
1 Year Est. Return
-26.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$217M
AUM Growth
-$20.4M
Cap. Flow
+$17.9M
Cap. Flow %
8.25%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
VERA icon
Vera Therapeutics
VERA
+$20.9M

Top Sells

Rank Stock Value
1
DM
Desktop Metal, Inc.
DM
+$2.95M

Sector Composition

Rank Sector Weight
1 Industrials 92.62%
2 Healthcare 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DM
1
DELISTED
Desktop Metal, Inc.
DM
$201M 92.62%
1,749,615
-22,500
-1% -$2.95M
VERA icon
2
Vera Therapeutics
VERA
$2.76B
$16M 7.38%
+1,343,152
New +$20.9M

Similar funds

LFF
Level Four Financial Dallas, Texas $229M AUM 47.67% 1-Year Est. Return
SCDF
Seahawk China Dynamic Fund Grand Cayman, Cayman Islands $217M AUM
SMR
SIH MPH Rollover New York $232M AUM 45.07% 1-Year Est. Return
CPWM
Cardinal Point Wealth Management Irvine, California $213M AUM 15.18% 1-Year Est. Return
CP
Columbus Point London, United Kingdom $210M AUM 24.14% 1-Year Est. Return
PP
Professional Planning Thousand Oaks, California $209M AUM 25.93% 1-Year Est. Return
PEA
Pacific Edge Advisors Corona Del Mar, California $206M AUM 26.47% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return

KPCB XVI Associates's Q2 2021 Portfolio in Review

As of Q2 2021, KPCB XVI Associates held 2 positions worth $217M, down 8.6% from $238M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XVI Associates deployed $17.9M of net new capital in Q2 2021, opening 1 new position. Its largest new stake was Vera Therapeutics: 1,343,152 shares worth $16M.

By sector, the portfolio is most concentrated in Industrials at 93% of assets, down from 100% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Desktop Metal, Inc., an estimated $2.95M trimmed.

  • KPCB XVI Associates's largest Q2 2021 buy was Vera Therapeutics: 1,343,152 shares worth $16M.
  • KPCB XVI Associates's biggest Q2 2021 reduction was Desktop Metal, Inc., cutting an estimated $2.95M.
  • KPCB XVI Associates's ten largest holdings make up 100% of its $217M portfolio in Q2 2021.
  • KPCB XVI Associates opened 1 new position and closed 0 in Q2 2021.
  • KPCB XVI Associates's portfolio value fell 8.6% quarter-over-quarter to $217M.

Based on KPCB XVI Associates's 13F filing for Q2 2021, filed 28 Jul 2021.